| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sivelestat | pancreatic elastase 1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spondylarthritis[MeSHID:D025241] Ulcerative Colitis[MeSHID:D003093] Pyoderma Gangrenosum[MeSHID:D017511] Multiple Sclerosis[MeSHID:D009103] Arthritis Psoriatic[MeSHID:D015535] Anterior uveitis[MeSHID:D014606] Crohn Disease[MeSHID:D003424] Rheumatoid Arthritis[MeSHID:D001172] |
10.61 | phase 3 | unknown |
| sivelestat | neutrophil elastase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spondylarthritis[MeSHID:D025241] Ulcerative Colitis[MeSHID:D003093] Pyoderma Gangrenosum[MeSHID:D017511] Multiple Sclerosis[MeSHID:D009103] Arthritis Psoriatic[MeSHID:D015535] Anterior uveitis[MeSHID:D014606] Crohn Disease[MeSHID:D003424] Rheumatoid Arthritis[MeSHID:D001172] |
17.68 | phase 3 | inhibitor |
| sivelestat | neutrophil elastase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spondylarthritis[MeSHID:D025241] Ulcerative Colitis[MeSHID:D003093] Pyoderma Gangrenosum[MeSHID:D017511] Multiple Sclerosis[MeSHID:D009103] Arthritis Psoriatic[MeSHID:D015535] Anterior uveitis[MeSHID:D014606] Crohn Disease[MeSHID:D003424] Rheumatoid Arthritis[MeSHID:D001172] |
17.68 | phase 3 | unknown |
| click here to return to the previous page | ||||||||